This site is intended for health professionals only

Friday 18 October 2019
Share |

Latest News

UK AI first to help nearly half a million with chronic conditions

Thursday 17th October 2019
A digital social enterprise and four UK health charities are coming together to harness the power of artificial intelligence (AI) to create the UK’s first AI coaching tool of its kind to support long-term health conditions.
Reason Digital is teaming up with Parkinson’s UK, the Stroke Association, Muscular Dystrophy UK and the MS Society to develop the project, which is set to transform the way medical advice and information is...
Tue, 17 Sep 2019
Assessors from the Joint Advisory Group (JAG) on Gastrointestinal Endoscopy, which is hosted by the Royal College of Physicians, visited the new unit at the Quadram Institute to ensure the Trust is meeting all regulatory requirements
Thu, 12 Sep 2019
The analysis included 474 patients presenting to the emergency department with acute coronary syndrome (myocardial infarction and unstable angina)
Thu, 12 Sep 2019
In the ASPIRE I & II trials, esketamine nasal spray plus standard of care was generally well-tolerated with no new safety signals
Thu, 12 Sep 2019
Across all efficacy endpoints, benefits were observed in patients treated with Imfinzi plus chemotherapy vs. SoC.
Thu, 12 Sep 2019
At five years, patients who were treated with nivolumab experienced a five-fold increase in long-term overall survival (OS) benefit versus docetaxel, with OS rates of 13.4% versus 2.6%, respectively
Thu, 12 Sep 2019
NHS Digital’s Hospital Accident and Emergency Activity 2018/19 also shows that attendances for the 20% of the population living in the most deprived areas accounted for 27% of all A&E attendances
Mon, 9 Sep 2019
The ECLS trial, conducted in Scotland with 12,209 patients, is believed to be the largest randomised controlled trial using blood biomarkers for the detection of lung cancer